家
倫理的意思決定支援
哲学/宗教
0
0
功利主義と義務論の枠組みに基づき、ビジネスの倫理的ジレンマに対する多角的な分析を提供し、管理者が道徳的に健全な意思決定を行うのを支援します。
プロンプト内容
コピー
コピー
Act as a corporate ethics consultant to evaluate the following business scenario: A pharmaceutical company discovers its best-selling drug has minor but negligible side effects with long-term use, yet concealing this information would cause a stock crash and impact employee benefits. Analyze the moral risks of concealment using both utilitarian consequentialism and Kantian deontology, weigh shareholder interests against patient safety, and provide a decision recommendation that balances compliance with corporate social responsibility, ensuring logical consistency and adherence to business ethical standards.
コピー
企業倫理コンサルタントとして、以下のビジネスシナリオを評価してください。製薬会社が、長期使用後に軽微だが無視できる副作用があるベストセラー医薬品を発見したが、この情報を隠蔽すると株価暴落と従業員福利厚生の影響が生じるケースです。功利主義の結果論とカントの義務論を用いて、隠蔽の道徳的リスクを分析し、株主の利益と患者の安全のバランスを取った上で、コンプライアンスと企業の社会的責任を両立する意思決定の提案を行い、論理的整合性とビジネス倫理基準への準拠を確保してください。
コピー
コメント (0)
0/300
おすすめ
倫理的意思決定支援
Act as a senior corporate ethics consultant to analyze the following specific business scenario: A pharmaceutical company developing a life-saving drug faces a dilemma regarding whether to partially release clinical trial data to accelerate approval, potentially sacrificing some subjects' privacy for greater public health benefits. Combine the utilitarian principle of maximizing happiness with the deontological respect for individual rights to evaluate the ethical risks of this decision. Provide a balanced solution that considers legal compliance, social responsibility, and long-term brand reputation, avoiding simple binary judgments, and focus on how to balance procedural justice with outcome justice.
倫理的意思決定支援
Please conduct an ethical analysis for the following specific business scenario: A pharmaceutical company discovers that its best-selling drug has a minor but foreseeable side effect with long-term use, increasing cardiovascular risk for patients, but discontinuing the drug would cause病情 worsening for some dependent patients. Please evaluate whether the company should proactively recall the drug and disclose side effects, combining the utilitarian principle of maximizing happiness for the greatest number with the deontological requirement of respecting patient autonomy and informed consent. Weigh the short-term financial loss against long-term brand trust and legal liability from the perspectives of stakeholders (patients, shareholders, employees, public), and finally provide a specific action recommendation that balances moral responsibility and corporate sustainability, explaining how this recommendation balances the interests of all parties.
倫理的意思決定支援
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company discovers during clinical trials that a drug has minor but long-term neurological side effects, yet it significantly extends the survival of late-stage cancer patients with no alternative therapies. Please analyze how the company should balance shareholder interests, patient health rights, and social responsibility by combining the utilitarian principle of maximizing happiness with the deontological perspective of respecting patient autonomy and the duty of non-maleficence, specifically regarding whether informed consent forms should explicitly mention these side effects, and provide specific communication strategies and ethical decision-making advice ensuring rigorous logic and compliance with modern business ethics standards.
倫理的意思決定支援
Please analyze the following specific ethical dilemma encountered in business operations: A pharmaceutical company discovers that its best-selling drug has mild but predictable side effects with long-term use, affecting the quality of life for some elderly patients, but discontinuing the drug would lead to more severe health risks. Please evaluate the moral rationality of three options—continuing sales, modifying label warnings, or initiating a recall—by combining the utilitarian principle of maximizing happiness with the deontological requirement of respecting patient autonomy, and provide a balanced recommendation that considers both corporate responsibility and patient well-being, ensuring the analysis is logically rigorous and compliant with business ethics standards.
倫理的意思決定支援
Act as a senior corporate ethics consultant to conduct a moral deduction for the following specific business scenario: A pharmaceutical company developing a life-saving new drug faces a situation where clinical trial data is partially missing, yet market demand is urgent. Please analyze the ethical consequences of continuing or pausing the trial by combining utilitarian considerations for the greatest good of the majority with deontological requirements for procedural justice, and provide specific action recommendations that balance legal compliance, social trust, and long-term business sustainability, ensuring the decision-making process is transparent and adheres to the highest industry ethical standards.
倫理的意思決定支援
Act as a corporate ethics consultant to conduct a deep moral analysis of the following specific business scenario: A pharmaceutical company discovers that its marketed drug has minor but non-fatal side effects with long-term use, yet withdrawing the product would cause the company to go bankrupt and affect thousands of patients relying on it. Please evaluate the moral weight of three options—withdrawal, continued sales with enhanced warnings, or voluntary recall with compensation—by integrating both utilitarian (maximizing overall well-being) and deontological (respecting patient autonomy and informed consent) ethical frameworks. Finally, provide a balanced decision recommendation that considers legal compliance, corporate survival, and patient rights, explaining its ethical justification.
